GSK-3 Inhibitors: Recent Developments and Therapeutic Potential

    September 2008 in “ Current signal transduction therapy ”
    Shinsuke Kaku, Shigeyuki Chaki, Makoto Muramatsu
    Studysummary This article reviews the role of glycogen synthase kinase-3 in various diseases and recent developments in GSK-3 inhibitors, without reporting any new clinical findings.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on eurekaselect.com →
    Discuss this study in the Community →